StocksHealthcareQTRX

QTRX

Quanterix Corporation
NasdaqResearch view
Healthcare · Laboratory Analytical Instruments · Micro-cap · SEC EDGAR FY 2025-12-31

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$145.2M
Enterprise Value$115.9M
Income$-107.2M
Sales$138.9M
Book/sh$6.25
Cash/sh$0.70
Dividend TTM
Payout
Employees
IPO
Quick Ratio2.11
Current Ratio2.84
Debt/Eq0.01
EPS (ttm)$-2.51
EPS this Y-151.0%
EPS past 3/5Y
Sales past 3/5Y9.6%
EPS Y/Y TTM-151.0%
Sales Y/Y TTM1.1%
Shs Outstand47.29M
ROA-25.6%
ROE-36.2%
ROIC-44.9%
Gross Margin46.8%
Oper. Margin-90.4%
Profit Margin-77.2%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$110.6M
2021
$105.5M
2022
$122.4M
2023
$137.4M
2024
$138.9M
2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%47%-90%-77%FY21FY22FY23FY24FY25

FY25 cash-flow waterfall

Cash-flow detail unavailable in this filing.
COMMUNITY · $QTRX0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.